Skip to main content
Premium Trial:

Request an Annual Quote

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

NEW YORK – Singapore-based Lucence Diagnostics and China's MEDx (Suzhou) Translational Medicine announced on Wednesday a strategic partnership aimed at cancer in China.

Under the agreement, the firms will codevelop companion diagnostic tests for PD-L1 rearrangement to be used with anti-PD1/PD-L1 cancer immunotherapies. Financial and other terms of the agreement were not disclosed.

"Immunotherapy is becoming more and more popular for drug development and personalized medicine in China," Nick Zhang, MEDx chairman and CEO, said in a statement. "We believe through this strategic partnership with Lucence, we will achieve better outcomes for cancer diagnosis and treatment selection for cancer patients."

Lucence's proprietary technology platform identifies PD-L1 rearrangement, while its multiplex immunofluorescence technology enables the prediction of anti-PD1/PD-L1 treatment outcomes. MEDx leverages high-throughput sequencing and bioinformatics for biomarker discovery and the development of cancer molecular diagnostics, they said.

Lucence offers genomic testing services through its CLIA-certified laboratory. It has previously partnered with the Singapore subsidiary of Beijing-based Novogene to develop NGS-based tests for precision cancer care for the Asian market.

MEDx is a translational research center focused on diagnostics and is the product of a Qiagen joint venture with BioBay.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.